nrevu@gitam.edu
LinkedIn
Google Scholar
Scopus
ORCiD
Dr. R. B. Nalanda is from Visakhapatnam, in Andhra Pradesh. She holds a Ph.D. in pharmaceutical analysis from Andhra University. Her specialization encompasses Analysis, Bioanalysis of active pharmaceutical ingredients in application to pharmacokinetics, and impurity profiling. She is committed to fostering and performing experimental plant-derived medicines and cosmetic analysis research. She is interested in creating collaborative and equitable research environments.
Research Publications
- Kapileswar S, Nalanda R, Pridhvi Krishna G. Development and Validation of UV Spectrophotometric Method for Estimation of Telmisartan by the Hydrotrophy Technique. International Journal of Pharmaceutical Research, 2021;13(3):337-343.
- Baby Nalanda R, Srinivasa Rao A, Kapileswar S, Srivani B. Quantitative determination of the PARP inhibitor Olaparib (AZD 2281) in rat plasma using LC-MS/MS: Application to pharmacokinetic studies. Journal of Pharmaceutical Research International, 2022; 34(39A), 41-48.
- Nalanda Baby R, Subhadip C. Determination of Sun Protection Factor (SPF) for various sunscreens by UV spectrophotometry. YMER, 2022;21(11):483-491.
- Nalanda Revu, Subhadip Chakraborty, Gita Surisetty. Estimation of Fisetin in Strawberry (Fragaria ananassa) by UV-Vis Spectrophotometry. Research and Innovation in Food Science and Technology, 2024;13:1-4.
- Varada Soujanya, Revu Baby Nalanda. Method development and validation for the simultaneous estimation of Doultegravir and Rilpivirine related impurities (Rilpivirine Z isomer and Doulutegravir hydroxy impurity) using RP-HPLC. Research Journal of Pharmacy and Technology, 2024;17(2): 595-602.
Expertise
-
Analytical and Bioanalytical validation studies
-
Quantification of impurities.
-
Separation and identification of phytochemicals
-
Spectrophotometric applications
